| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9271 |
Injection, pembrolizumab, 1 mg |
288 |
225 |
$1.65M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
34,263 |
20,074 |
$1.40M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
15,768 |
6,120 |
$888K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
7,634 |
3,593 |
$689K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
9,441 |
3,916 |
$656K |
| P9046 |
Infusion, albumin (human), 25%, 20 ml |
2,892 |
1,071 |
$314K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14,052 |
10,259 |
$286K |
| 99215 |
Prolong outpt/office vis |
4,327 |
3,252 |
$280K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,136 |
1,647 |
$194K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,318 |
18,549 |
$176K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
5,385 |
3,176 |
$166K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
25,552 |
15,790 |
$154K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
12,340 |
4,620 |
$142K |
| 96367 |
|
3,576 |
1,663 |
$141K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
302 |
167 |
$68K |
| J3480 |
Injection, potassium chloride, per 2 meq |
2,533 |
791 |
$67K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,224 |
427 |
$49K |
| J7050 |
Infusion, normal saline solution, 250 cc |
9,039 |
4,972 |
$49K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,036 |
2,606 |
$44K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,470 |
1,152 |
$41K |
| 96415 |
|
768 |
422 |
$35K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
3,723 |
2,076 |
$34K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,366 |
538 |
$32K |
| J0897 |
Injection, denosumab, 1 mg |
64 |
62 |
$31K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
8,941 |
7,450 |
$29K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
6,015 |
1,575 |
$28K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
95 |
65 |
$28K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,653 |
1,415 |
$22K |
| 96417 |
|
372 |
243 |
$20K |
| J1453 |
Injection, fosaprepitant, 1 mg |
191 |
105 |
$18K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
327 |
193 |
$18K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
3,843 |
2,098 |
$17K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,432 |
2,619 |
$14K |
| 99245 |
|
59 |
57 |
$11K |
| 99233 |
Prolong inpt eval add15 m |
209 |
82 |
$10K |
| Q5122 |
Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg |
15 |
13 |
$10K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,182 |
675 |
$7K |
| S0028 |
Injection, famotidine, 20 mg |
1,145 |
677 |
$6K |
| 96411 |
|
139 |
73 |
$4K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
33 |
24 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,532 |
695 |
$3K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
26 |
12 |
$993.16 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
423 |
245 |
$975.06 |
| 80076 |
|
6,674 |
5,318 |
$681.11 |
| J3490 |
Unclassified drugs |
1,083 |
677 |
$667.18 |
| 82728 |
|
2,925 |
2,783 |
$608.71 |
| 83735 |
|
3,954 |
1,822 |
$484.92 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
19 |
15 |
$477.15 |
| 85610 |
|
170 |
122 |
$361.86 |
| J9190 |
Injection, fluorouracil, 500 mg |
27 |
13 |
$357.82 |
| 96523 |
|
17 |
13 |
$336.86 |
| 80053 |
Comprehensive metabolic panel |
685 |
626 |
$276.87 |
| 83615 |
|
2,994 |
2,595 |
$270.19 |
| 82607 |
|
1,054 |
1,036 |
$240.64 |
| 82378 |
|
415 |
364 |
$200.05 |
| 82746 |
|
1,206 |
1,179 |
$199.59 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
27 |
13 |
$136.69 |
| J2060 |
Injection, lorazepam, 2 mg |
22 |
12 |
$58.85 |
| 84443 |
Thyroid stimulating hormone (TSH) |
315 |
301 |
$49.63 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
50 |
24 |
$30.27 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
30 |
12 |
$25.44 |
| 86140 |
|
118 |
114 |
$13.50 |
| 84439 |
|
178 |
168 |
$13.24 |
| 99000 |
|
9,146 |
5,433 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
2,754 |
1,784 |
$0.00 |